RIPTAC Trademark

Trademark Overview

On Thursday, January 5, 2023, a trademark application was filed for RIPTAC with the United States Patent and Trademark Office. The USPTO has given the RIPTAC trademark a serial number of 97742256. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 23, 2024. This trademark is owned by Halda Therapeutics OpCo, Inc.. The RIPTAC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Medical research; Pharmaceutical research and development; Research and development in the field of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of pharmaceuticals, medicine, and disease treatment
riptac

General Information

Serial Number97742256
Word MarkRIPTAC
Filing DateThursday, January 5, 2023
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesBiochemical research and development; Medical research; Pharmaceutical research and development; Research and development in the field of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; Research and development of vaccines and medicines; Scientific research; Scientific research and development; Scientific research in the field of pharmaceuticals, medicine, and disease treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 29, 2023
Primary Code042
First Use Anywhere DateMonday, January 2, 2023
First Use In Commerce DateMonday, January 2, 2023

Trademark Owner History

Party NameHalda Therapeutics OpCo, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511
Party NameHalda Therapeutics OpCo, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06511

Trademark Events

Event DateEvent Description
Monday, January 9, 2023NEW APPLICATION ENTERED
Sunday, January 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2023ASSIGNED TO EXAMINER
Thursday, September 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 29, 2024USE AMENDMENT FILED
Monday, January 29, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, February 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Friday, April 5, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, April 5, 2024NON-FINAL ACTION E-MAILED
Friday, April 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 3, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, June 24, 2024SOU EXTENSION 1 FILED
Wednesday, July 3, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 31, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, November 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 23, 2024ASSIGNED TO LIE

Related Keywords

riptac research development scientific pharmaceuticals field medicines vaccines treatment medicine disease